Midea VRF Going Global, Sets Sail for Jakarta-Bandung High-speed Railway
The G20 Bali Summit presented the latest construction results of the Jakarta-Bandung High-speed Railway (HSR), the first high-speed railway in Southeast Asia. With a total length of 142 kilometers and a maximum design speed of 350 kilometers per hour, marking that Indonesia has entered the "high-speed rail era". Midea provides professional HVAC solutions and the most intimate services and sends "Midea Coolness" for Jakarta-Bandung HSR with 126 ODUs and 705 IDUs of Midea VC Pro.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221115006013/en/
Midea VC Pro VRFs have been used in Jakarta-Bandung High-Speed Railway (HSR), Dubai Expo and many other overseas projects. (Graphic: Business Wire)
The HVAC project is vital equipment support for Jakarta-Bandung HSR. Jakarta-Bandung Railway is located in the tropical rainforest climate zone of Java Island and is influenced by the equatorial climate. The operator of the HSR needs a reliable and stable central air conditioning system to adapt to the high temperature and high humidity working conditions without downtime and effectively maintain the constant temperature of the HSR building space.
With a leading position in the global HVAC industry, Midea Building Technologies provides Jakarta-Bandung HSR professional air conditioning solutions. The multi-fluid chip liquid cooling technology can cool the electric control parts in time, and about 8 degrees can reduce the average temperature of the electric control parts, which can maintain strong cooling in high-temperature environments. In terms of corrosion resistance, the VC Pro VRFs ODUs can still operate stably under the severe corrosion of salt pollution environment by simulating experimental tests.
Besides facing the problems of a large construction area and high population flow in the HSR station, Site 4, which Midea MBT won the bid for, containing six building types such as station buildings, apartment buildings, etc., is the most complex site for the installation of central air conditioning for the Jakarta-Bandung HSR. Moreover, in Indonesia, the procurement of installation materials for the project was restricted in many ways. All aspects had to be evaluated in the process of selection. The air conditioning design plan was also updated again and again and refined over and over again. Finally, the optimal quality and efficiency of the HVAC installation project were achieved with the combination of multi-type design and multi-layout form.
Midea VC Pro VRFs have also been used in Dubai Expo and many other overseas projects. Now, Midea Building Technologies has localized its sales and service networks in the international market, forming a comprehensive layout from core technology, and original products to differentiated customized solutions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IFF Announces Grant of Employment Inducement Awards1.3.2024 22:15:00 CET | Press release
IFF (NYSE: IFF) today announced the grant of employment inducement awards to J. Erik Fyrwald, IFF Chief Executive Officer and member of the Board of Directors. The Company's Board of Directors approved the employment inducement awards on Jan. 9, 2024, with a grant date of March 1, 2024, as a material inducement to enter into an offer of employment in reliance on the employment inducement award exception to New York Stock Exchange Listing Rule 303A.08 that requires shareholder approval of equity-based compensation plans. Listing Rule 303A.08 requires the public announcement of such an award. The inducement awards will consist of (i) a target award of 68,750 performance share units (with a maximum award of 171,875 performance share units), subject to meeting the applicable performance targets set forth in the award agreement, and (ii) 56,250 restricted stock units, 100% of which will vest on the three-year anniversary of the grant date, for a maximum potential combined payout of 228,125
Whitehorse Liquidity Partners Recognized by Private Equity International’s 2023 Awards1.3.2024 16:30:00 CET | Press release
Whitehorse Liquidity Partners (together with its advisory affiliates, “Whitehorse”), a specialized investment manager focused on providing structured liquidity solutions to the alternative asset class, is pleased to announce recognition from Private Equity International (PEI) in the 2023 PEI Awards. Whitehorse placed third in the Secondaries Firm of the Year in the Americas category alongside Blackstone Strategic Partners and HarbourVest Partners and was voted Firm of the Year in Canada. “We are honoured to have been recognized again in two categories by the PEI Awards,” said Yann Robard, Managing Partner of Whitehorse. “For the fourth time among the top three Secondaries Firm of the Year in the Americas category (2018, 2020, 2022 and 2023) and the sixth time among the top three in the Firm of the Year in Canada category (2017, 2018, 2020, 2021, 2022 and 2023). You often hear us say that big is beautiful, growth is good and scale matters. Our scale has enabled us, not disrupted us. We
Calvin Klein Fragrances announces Idris and Sabrina Elba as the face of new Calvin Klein ETERNITY AROMATIC ESSENCE fragrance campaign1.3.2024 14:30:00 CET | Press release
Calvin Klein, Inc., a wholly owned subsidiary of PVH Corp. (NYSE: PVH), and Calvin Klein Fragrances, a division of Coty Inc. (NYSE: COTY), today unveil actor and musician Idris Elba and his wife, model and human rights activist Sabrina Elba as the faces of Calvin KleinETERNITY AROMATIC ESSENCE, the newest addition to the ETERNITYfragrance portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240301420936/en/ Calvin Klein Fragrances announces Idris and Sabrina Elba as the face of new Calvin Klein ETERNITY AROMATIC ESSENCE fragrance campaign (Photo: Business Wire) Shot by Mert Alas, the campaign offers a fresh and impactful take on ETERNITY’s timeless dream of eternal love, capturing Idris and Sabrina in moments of intimacy set to a bespoke cover of “Fever” by FKA twigs. The striking campaign imagery is inspired by profound connection and the essence of desire, paying tribute to ETERNITY’s legacy of sensuality by partnerin
Wellness Market Leaders Join Forces: The DRIPBaR Powered by REVIV1.3.2024 13:35:00 CET | Press release
The DRIPBaR, recognized as the fastest-growing IV therapy franchise in the United States, has joined forces with REVIV, the global leader in IV therapy, marking a significant milestone for the industry. The partnership creates an unrivaled offering by bringing together the specialties of two industry heavyweights boasting over 200 locations across 6 continents, with plans to add thousands more locations in the coming years. The recent surge in demand for IV therapy presents enormous opportunities globally for the companies to redefine industry standards and spearhead the next era of IV therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240301173923/en/ Ben Crosbie, CEO of The DRIPBaR and Sarah Lomas, Founder and CEO of REVIV Global, announce their exciting partnership. (Photo: Business Wire) With an extensive pipeline boasting over 450 franchisees in the United States, The DRIPBaR's decision to integrate REVIV's proprie
GENESIS Pharma Announces an Exclusive Distribution Agreement With Regeneron Pharmaceuticals to Commercialize cemiplimab in Greece, Cyprus and Malta1.3.2024 09:37:00 CET | Press release
GENESIS Pharma, a regional biopharma company specialized in the commercialization of innovative medicines targeting severe and rare diseases in Central and Eastern Europe, announces an exclusive distribution agreement for the cancer medicine cemiplimab in Greece, Cyprus and Malta with Regeneron Ireland DAC. Regeneron Ireland DAC is a wholly owned subsidiary of Regeneron, a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Cemiplimab is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells and was invented using Regeneron's proprietary VelocImmune® technology. In the European Union, cemiplimab is indicated for adults as monotherapy treatment for certain patients with locally advanced or metastatic basal cell carcinoma (BCC), as monotherapy treatment for certain patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC), as both monotherapy o